Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate

Journal of Obstetrics and Gynaecology

Volumn 26, Issue 7, 2006, Pages 673-678

  Kriplani, A ^a   Kulshrestha, V ^a   Agarwal, N ^a,b   Diwakar, S ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE; TRANEXAMIC ACID;

ADULT; ALLERGIC REACTION; ARTICLE; BLEEDING; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENORRHAGIA; METRORRHAGIA; MOOD CHANGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; ANTIFIBRINOLYTIC AGENTS; CONTRACEPTIVES, ORAL, SYNTHETIC; FEMALE; HUMANS; MEDROXYPROGESTERONE; MENORRHAGIA; MIDDLE AGED; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 33750518161     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610600913932     Document Type: Article

References (25)

1. Bonnar J, Sheppard BL. 1996. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid and tranexamic acid. British Medical Journal 313:579-582.
2. Bonnar J, Sheppard BL, Dockeray CJ. 1983. The haemostatic system and dysfunctional uterine bleeding. Research and Clinical Forums 5:27-38.
3. Callender ST, Warner GT, Cope E. 1970. Treatment of menorrhagia with tranexamic acid: a double blind trial. British Medical Journal 4:214-216.
4. Cameron IT, Haining R, Lumsden MA, Thomas VR, Smith SK. 1990. The effects of mefenamic acid and norethisterone on measured blood loss. Obstetrics and Gynecology 76:85-88.
5. Coulter A, Kelland J, Peto V, Rees MCP. 1995. Treating menorrhagia in primary care: an overview of drug trials and survey of prescribing practice. International Journal of Technology Assessment in Health Care 11:456-471.
6. Dicker RC, Geenspan JR, Stauss LT et al. 1982. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. American Journal of Obstetrics and Gynaecology 144:841-848.
7. Fraser IS. 1990. Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progesterone. Australian and New Zealand Journal of Obstetrics and Gynaecology 30:353-356.
8. Fraser IS, McCarron G. 1991. Randomised trial of two hormonal and two prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Australian and New Zealand Journal of Obstetrics and Gynaecology 31:66-70.
9. Gleeson NC, Buggy F, Sheppard BL, Bonnar J. 1994. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding. Acta Obstetricia et Gynecologica Scandinavica 73:274-277.
10. Higham JM, O'Brien PM, Shaw RW. 1990. Assessment of menstrual blood loss using a pictorial chart. British Journal of Obstetrics and Gynaecology 97:734-739.
11. Intercontinental Medical Statistics Ltd. 1994. United Kingdom and Ireland. London: IMS Ltd.
12. Irvine GA, Cameron IT. 1999. Medical management of dysfunctional uterine bleeding. Baillieres Best Practice and Research Clinical Obstetrics and Gynaecology 13:189-202.
13. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT. 1998. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. British Journal of Obstetrics and Gynaecology 105:592-598.
14. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. 1998. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 351:485-489.
15. Lethaby A, Irvine G, Cameron I. 2000. Cyclical progesterones for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2:CD001016.
16. Lethaby A, Farquhar C, Cooke I. 2001. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 4:CD000249.
17. Liu DTY. 1995. Treatment of dysfunctional uterine bleeding. Amenorrhoea need not be an end point. British Medical Journal 310:802.
18. Macdonald R. 1990. Modern treatment of menorrhagia. British Journal of Obstetrics and Gynaecology 97:3-7.
19. Milsom I, Anderson K, Andersch B, Rybo G. 1991. A comparison of flurbiprofen, tranexamic acid and a levonorgestrel releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology 164:879-883.
20. Munro MG. 2000. Medical management of abnormal uterine bleeding. Obstetrics and Gynecology Clinics of North America 27:287-304.
21. Nilsson L, Rybo G. 1967. Treatment of menorrhagia with an antifibrinolytic agent, tranexamic acid. Acta Obstetricia et Gynecologica Scandinavica 46:572-580.
22. Preston JT, Cameron IT, Adams EJ, Smith SK. 1995. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. British Journal of Obstetrics and Gynaecology 102:401-406.
23. Rybo G. 1991. Tranexamic acid therapy; effective treatment in heavy menstrual bleeding. Therapeutic Advances 4:1-8.
24. Rydin E, Lundberg PO. 1976. Letter: Tranexamic acid and intracranial thrombosis. Lancet 2:49.
25. Wellington K, Wagstaff AJ. 2003. Tranexamic acid: A review of its use in the management of Menorrhagia. Drugs 63:1417-1433.